Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Utilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other Diseases.
Cholinergic system and neuroinflammation: Implication in multiple sclerosis.
Chronic inflammatory demyelinating polyneuropathy associated with manic symptoms.
Autologous hematopoietic cell transplantation in multiple sclerosis.
Rapid Simultaneous High-resolution Mapping of Myelin Water Fraction and Relaxation Times in Human Brain using BMC-mcDESPOT.
Long-term effects of autoimmune CNS inflammation on adult hippocampal neurogenesis.
Acute disseminated encephalomyelitis in a case of autoimmune haemolytic anaemia: a rare association.
IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases.
Sex differences and subclinical retinal injury in pediatric-onset MS.
Hemoglobins as new players in multiple sclerosis: metabolic and immune aspects.
5-Hydroxymethylcytosine Remodeling Precedes Lineage Specification during Differentiation of Human CD4(+) T Cells.
Fampridine and quality of life in individuals with multiple sclerosis.
Reprogramming A375 cells to induced‑resembled neuronal cells by structured overexpression of specific transcription genes.
Analysis of multiple sclerosis patients with electrophysiological and structural tests.
Microglia response in retina and optic nerve in chronic experimental autoimmune encephalomyelitis.
The role of microRNAs in the pathogenesis of autoimmune diseases.
Dimethyl fumarate alters microglia phenotype and protects neurons against proinflammatory toxic microenvironments.
Bladder function and falls in individuals with multiple sclerosis.
Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment.
Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice.
Healthy Life-Years Lost and Excess Bed-Days Due to 6 Patient Safety Incidents: Empirical Evidence From English Hospitals.
Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis.
Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses.
Geomagnetic disturbance: A new field in multiple sclerosis research.
Pages
« first
‹ previous
…
824
825
826
827
828
829
830
831
832
…
next ›
last »